Other Stories

S. Korea added to EU drug whitelist, which is expected to streamline pharma exports to Europe Updated: 2019-05-15 12:46:25 KST

South Korea has been added to the EU drug whitelist, a move that's expected to boost the country's exports of pharmaceutical ingredients and products.
The decision was reached by the European Council on Tuesday, about four years after Seoul applied in early 2015.
It certifies that South Korea's medicine-related manufacturing and supervision standards comply with those of the EU.
Such a move is expected to streamline the process for the Korean pharmaceutical industry to access the EU market, which accounts for 31 percent of South Korea's pharmaceutical exports.
Seoul's Ministry of Food and Drug Safety forecasts it will save up to four months in the export process.
The ministry says it will strengthen global cooperation to expand entry into the global market based on the high quality of South Korea's medical goods, and participate proactively in international exchanges.
South Korea becomes the seventh country to get on the whitelist, following other nations, including the U.S., Japan, Brazil and Australia.
Kim Hyo-sun, Arirang News.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.